Clinical trials
Phase 1/2 Bone Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Not yet recruiting | 4 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shenzhen Geno-Immune Medical Institute | 2 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| China Medical University Hospital | 1 |
| Grupo Espanol de Investigacion en Sarcomas | 1 |
| Institute of Mother and Child, Warsaw, Poland | 1 |
| National Cancer Institute (NCI) | 1 |
| Roswell Park Cancer Institute | 1 |
| Shanghai 6th People's Hospital | 1 |
| UMC Utrecht | 1 |
| University Hospital, Strasbourg, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Neoplasms | 11 |
| Sarcoma | 5 |
| Sarcoma, Ewing | 5 |
| Osteosarcoma | 4 |
| Carcinoma, Renal Cell | 1 |
| Chondrosarcoma | 1 |
| Colorectal Neoplasms | 1 |
| Hemangioendothelioma | 1 |
| Hemangioendothelioma, Epithelioid | 1 |
| Hemangiosarcoma | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.